Value Added Services in Cardiometabolic Diseases -- Payer views

Wednesday, November 29, 2017 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 28, 2017 /PRNewswire/ -- Pharma's Value-Added Services (VAS) in cardiometabolic disease are not universally

appreciated – why? Too often, useful programmes to monitor, educate and support patients are quietly dropped post launch. No wonder there is a widespread cynical view among payers that many "beyond the pill" support services are little more than a marketing
ploy. How can Pharma get back on track and deliver sustained VAS that innovatively support long-term cardiometabolic disease patients, change behaviour and build trust with payers? Value-added Services in Cardiometabolic Diseases meets head-on the current criticism of many VAS initiatives, and through the hard-hitting insights of senior US and EU payers, clearly identifies the key VAS design, development and areas for improvement that industry needs to address. Download the full report: https://www.reportbuyer.com/product/5214611Answering key questions: Reasons to buy this report VAS have become a standard feature of pharma's outreach and companies can point to a raft of monitoring, education and health support services that have made a real impact. So why are payers sceptical and how is that impacting pharma's prospects? Short lived VAS are not building trust with payers or fully meeting the long-term needs of patients – especially in chronic conditions such as diabetes. It can be better. In this report experienced US and EU payers identify what good, on-target VAS look like, how working with payers can lead to better VAS solutions and how sharing outcomes data can help prove product value to a company's commercial benefit. This report will enable you to: • Plan VAS into the product lifecycle to support patients with chronic cardiometabolic diseases • Leverage real world VAS outcomes data to support value claims with payers • Work collaboratively with payers to design innovative VAS programmes • Learn why working with trusted independent 3rd parties to deliver VAS will gain payer approval • Innovate to address non-adherence in a patient-centric way • Understand how US and EU5 payers' views of VAS vary and nuance your programmes to meet local conditions Download the full report: https://www.reportbuyer.com/product/5214611 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com

 

View original content:http://www.prnewswire.com/news-releases/value-added-services-in-cardiometabolic-diseases----payer-views-300563283.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store